mRNA-4157,Pembrolizumab
Moderna,Merck
['melanoma', '$mrna', '$bntx']
$mrna #aacr mrna individualized neoantigen therapy looking increasingly promising. 44% risk reduction of recurrence or death in phase 2b melanoma study, few if any meaningful side effects. $bntx
Natural born biotech stock trader/investor. Trained in RNAi, extremely excited about RNA Editing. 

Not investment advice